Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Steve, I agree that that article implied Lombardo is not selling the company and wants to stay in New Jersey a long time. However, he could have said that to send the signal that unless a buyer is willing to step up and pay an attractive price for ADXS/fair value at least in the $20s then the company is not for sale.

I don't think we will see another dilution, surely not at the current multi year low price. If you read the press release talking about Lombardo's new role, the Board made a comment that they now believe the CEO is aligned with the Board. I interpreted this to mean that O'Connor was not aligned with the Board, most likely because O'Connor was not creating value/not striking any monetary deals on our late stage assets while relying too much on diluting investors.